Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology
Sharon P. Shriver, Devon V. Adams, Brittany McKelvey, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 10, pp. 1181-1192
Open Access | Times Cited: 11

Showing 11 citing articles:

Integrating Pharmacogenomics into the Broader Construct of Genomic Medicine: Efforts by the ClinGen Pharmacogenomics Working Group (PGxWG)
Li Gong, Clarissa Klein, Kelly E. Caudle, et al.
Clinical Chemistry (2025) Vol. 71, Iss. 1, pp. 36-44
Closed Access
Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs
Hean Koo, Tayler B. Smith, John T. Callaghan, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
Pharmacogenomics for Nurses
Dennis J. Cheek, Trina Walker
Nursing Clinics of North America (2025)
Closed Access
Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointestinal registry
Teresa Macarulla, Andrés J. Muñoz Martín, Eva Martínez de Castro, et al.
ESMO Real World Data and Digital Oncology (2025) Vol. 7, pp. 100116-100116
Open Access
A National Study Among Diverse US Populations of Exposure to Prescription Medications with Evidence‐Based Pharmacogenomic Information
Loren Saulsberry, J. Jameson, Robert D. Gibbons, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
Strategies for DPYD testing prior to fluoropyrimidine chemotherapy in the US
Tabea Tracksdorf, D. Max Smith, Skyler Pearse, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 8
Closed Access | Times Cited: 3
Understanding the Biology and Testing Techniques for Pharmacogenomics in Oncology: A Practical Guide for the Clinician
Nury Steuerwald, Sarah Morris, D. Grace Nguyen, et al.
JCO Oncology Practice (2024) Vol. 20, Iss. 11, pp. 1441-1451
Closed Access | Times Cited: 2
Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes
Roman Tremmel, Daniel Hübschmann, Elke Schaeffeler, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100014-100014
Open Access | Times Cited: 1
Strategies for DPYD Testing Prior to Fluoropyrimidine Chemotherapy in the United States
Tabea Tracksdorf, D. Max Smith, Skyler Pearse, et al.
Research Square (Research Square) (2024)
Open Access
Roadmap for the next generation of Children’s Oncology Group rhabdomyosarcoma trials
Jonathan Metts, Jamie M. Aye, Jacquelyn Crane, et al.
Cancer (2024) Vol. 130, Iss. 22, pp. 3785-3796
Closed Access
The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation
Larisa H. Cavallari, J. Kevin Hicks, Jai N. Patel, et al.
Pharmacogenetics and Genomics (2024) Vol. 35, Iss. 1, pp. 1-11
Closed Access
The impact of pharmacogenomics on a pharmacy and therapeutic committee's formulary system management: An opinion of the pharmacokinetics/pharmacodynamics/pharmacogenomics practice and Research Network for the American College of Clinical Pharmacy
Jacob T. Brown, Micheline Andel Goldwire, Amanda Massmann, et al.
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2024)
Open Access
Page 1

Scroll to top